PI 3-kinase inhibitors and methods of their use
Details for Australian Patent Application No. 2008213808 (hide)
International Classifications
Event Publications
6 August 2009 PCT application entered the National Phase
PCT publication WO2008/098058 Priority application(s): WO2008/098058
24 September 2009 Corrigenda
PCT applications that have entered the National Phase - Name Index Under the Name Novartis Vaccines and Diagnostics, Inc., Application No. 2008213808, under INID (54) correct the title to read PI 3-kinase inhibitors and methods of their use Corrigenda
5 November 2009 Amendment Made
The nature of the amendment is: Amend the applicant name from Novartis Vaccines and Diagnostics, Inc. to Novartis AG
10 November 2011 Application Accepted
Published as AU-B-2008213808
22 March 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008213811-System and method for joint resurface repair
2008213772-Composition comprising terpene compounds and methods for inhibiting nerve transmission
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser